Clinical Trial Update: SHP-141C in Plaque Type Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of SHP-141C for plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SHP-141C

Snippet

Sponsor: TetraLogic Pharmaceuticals | Conditions: Plaque Type Psoriasis | Phase 1 | Status: COMPLETED